The Link Between Lynch Syndrome and Ovarian Cancer

Lynch syndrome and ovarian cancer are closely connected. Yet this link remains widely underdiagnosed and misunderstood. If you or someone you love carries a Lynch syndrome gene mutation, understanding that risk could genuinely be life-saving.

Here’s what you need to know.

What Is Lynch Syndrome?

Lynch syndrome is an inherited condition caused by mutations in specific genes that help the body repair DNA damage. When those genes don’t work properly, cells are more likely to develop errors that can lead to cancer.

It used to be called hereditary non-polyposis colorectal cancer (HNPCC), because colorectal cancer is its most well-known associated risk. But Lynch syndrome raises the risk of several other cancers, too — including endometrial (uterine) cancer and ovarian cancer.

The genes involved are MLH1, MSH2, MSH6, PMS2, and EPCAM. Each mutation carries different levels of risk for different cancers, which is why speaking with a genetic counselor matters so much.

Lynch syndrome is more common than most people think. Research estimates it affects approximately 1 in 280 people in the United States, yet the vast majority of carriers have no idea. 

How Does Lynch Syndrome Raise Ovarian Cancer Risk?

Every time a cell divides, tiny DNA copying errors occur. In most people, the body catches and corrects these mistakes. In people with Lynch syndrome, those repair genes aren’t working properly: meaning, errors can accumulate and eventually lead to cancer.

Because these faulty genes exist in virtually every cell of the body from birth, they can affect many different organs,  including the ovaries.

The lifetime risk of ovarian cancer in the general population is about 1.3%. For women with Lynch syndrome, that risk rises significantly depending on which gene is mutated:

• MLH1 mutation: up to 20% lifetime risk of ovarian cancer
• MSH2/EPCAM mutation: up to 38% lifetime risk
• MSH6 mutation: up to 13% (evidence is less definitive)
• PMS2 mutation:  lifetime risk appears similar to the general population in most studies, though NCCN estimates a range of 1.3–3%; evidence to date has not demonstrated a statistically significant increased relative risk

That’s a meaningful difference, especially because Lynch syndrome-associated ovarian cancer tends to strike younger.

Who Gets Diagnosed, and When?

One of the most important distinctions between Lynch syndrome-related ovarian cancer and the general ovarian cancer population is age.

The average age of ovarian cancer diagnosis in the general population is around 63. For women with Lynch syndrome, the mean age at diagnosis is closer to 43 to 51. 

In a study of Lynch-syndrome carriers with ovarian cancer, 85% were diagnosed at stage I or II. Their 5-year overall survival rate was 80%. That’s significantly better than average survival rates for ovarian cancer overall.

What Type of Ovarian Cancer Is Most Common in Lynch Syndrome?

Most ovarian cancer in the general population is high-grade serous (HGSOC), the type most people picture when they think of ovarian cancer. It tends to be aggressive and is strongly associated with BRCA mutations.

Lynch syndrome-associated ovarian cancer is different. The most common histological subtype is endometrioid adenocarcinoma, which accounted for over half of cases in the largest reported case series to date.

Clear cell tumors also occur, making up roughly 10% of cases in larger histological studies, with mixed tumors carrying an endometrioid component accounting for another 20%. 

High-grade serous ovarian cancer — the most common subtype in the general population — appears to be rare in Lynch syndrome, with some of the largest histological studies finding no HGSOC cases at all. This distinct histological profile, dominated by endometrioid tumors that tend to be lower grade and caught earlier, helps explain the comparatively better prognosis seen in this group.

This also means that what works for BRCA-associated ovarian cancer doesn’t automatically apply to Lynch syndrome cases. They’re biologically distinct, and research needs to reflect that.

Symptoms of Ovarian Cancer to Watch For

Lynch syndrome itself doesn’t cause symptoms. The concern becomes symptoms of the cancers it predisposes you to.

Ovarian cancer symptoms are often vague and easy to dismiss, which is exactly why they go undetected for so long. If you have Lynch syndrome, pay close attention to:

• Persistent bloating or abdominal swelling
• Pelvic or abdominal pain
• Feeling full quickly or difficulty eating
• Needing to urinate more frequently or urgently
• Unexplained weight changes
• Unusual fatigue

These symptoms can have many causes. But if they’re new, persistent, or getting worse — especially if you have a known Lynch syndrome mutation — don’t wait. Push for evaluation. 

How Is Lynch Syndrome Diagnosed?

Diagnosis typically involves a few steps.

If someone in your family has already been diagnosed with Lynch syndrome, a targeted blood or saliva genetic test can tell you whether you carry the same mutation. This is called cascade testing.

If no one in your family has been tested, but you have a personal or family history of Lynch-related cancers — especially colorectal or endometrial cancer diagnosed before age 50 — your doctor may recommend:

• Tumor testing (immunohistochemistry or microsatellite instability testing) on any cancer tissue
• Multigene panel testing to screen for a broad range of hereditary cancer-related gene mutations, including those associated with Lynch syndrome

The Society of Gynecologic Oncology recommends that all women diagnosed with ovarian cancer undergo genetic testing — not just for BRCA mutations, but for Lynch syndrome as well.  

Screening for Ovarian Cancer if You Have Lynch Syndrome

There’s no proven, reliable screening test for ovarian cancer in the general population. The situation is similar, but more nuanced, for Lynch syndrome carriers.

Transvaginal ultrasound and CA-125 blood tests can be offered and may catch something early, but neither has been shown to definitively reduce mortality from ovarian cancer in Lynch syndrome patients. 

Risk-Reducing Surgery: Is It Right for You?

For women with Lynch syndrome who have completed their families, risk-reducing surgery is one of the most effective options available.

Prophylactic hysterectomy with bilateral salpingo-oophorectomy (removal of the uterus, fallopian tubes, and ovaries) has been shown to eliminate ovarian cancer risk in Lynch syndrome carriers who undergo the procedure. 

Most professional organizations recommend considering this surgery between ages 40 and 45 — though earlier may be appropriate depending on your specific mutation and family history.

This is a deeply personal decision. Removing the ovaries before natural menopause brings its own health considerations, including surgery-induced menopause and effects on bone health. It’s worth exploring your options, including the possibility of opportunistic salpingectomy in some situations, with a specialist.

Speaking with a gynecologic oncologist who has experience in hereditary cancer syndromes is essential before making any surgical decisions.

Ongoing clinical trials are investigating whether immunotherapy should be used earlier in treatment — even before surgery in some cases. This is promising territory for the years ahead.

If you’ve been diagnosed with ovarian cancer and haven’t been tested for Lynch syndrome, ask your doctor about genetic testing and tumor profiling now. It could open doors to treatment options that wouldn’t otherwise be considered.

What About Family Members?

If you’re diagnosed with Lynch syndrome, your biological relatives (parents, siblings, children) each have a 50% chance of carrying the same mutation.

That’s not a reason to panic. It’s a reason to act.

Cascade testing allows family members to find out their status with a simple blood or saliva test. Those who test positive can then begin surveillance and risk reduction proactively. 

Talking to family about genetic risk is rarely easy. But it’s one of the most meaningful things you can do — for them and for yourself.

Final Thoughts: Understanding The Lynch Syndrome – Ovarian Cancer Link  

A Lynch syndrome diagnosis is a lot to process. But knowing — even when the news hits hard — puts you in a position to act. 

Ovarian cancer is a disease that has historically been caught too late. For women with Lynch syndrome, the earlier age of onset makes awareness and proactive monitoring genuinely critical. 

That means staying in close contact with a gynecologic oncologist who understands hereditary cancer syndromes, learning to recognize ovarian cancer symptoms, and having honest conversations with your family about their own risk.

None of this is easy. But the women who fare best are typically the ones who pushed for answers, asked hard questions, and refused to be dismissed. Remember: knowing your risk isn’t cause for fear. It’s cause for action.